Prolactin and growth hormone signaling

被引:44
作者
Chilton, BS [1 ]
Hewetson, A [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA
来源
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOLUME 68 | 2005年 / 68卷
关键词
D O I
10.1016/S0070-2153(05)68001-5
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prolactin (PRL) and growth hormone (GH) act by way of their receptors as either hormones (systemically) or cytokines (locally). The Jak2/Stat5 pathway is the principal route by which PRL/GH activate target genes. The availability of knockout mice for each member of this signaling cascade has provided opportunities to understand their unique interactions. Jak2 is important in alternative signal transduction schema such as the MAP kinase and PI3K/Akt pathways. The putative Jak2/RUSH pathway is based on the fact that RUSH mediates the ability of PRL to augment progesterone-dependent gene transcription. New evidence shows that suppressors, regulators, and degraders control Jak2/Stat5. This review focuses on the most recent advances in the field of PRL/GH signal transduction. (c) 2005, Elsevier Inc.
引用
收藏
页码:1 / 23
页数:23
相关论文
共 103 条
[51]   TRANSCRIPTIONAL REGULATION BY THE HELIX BUNDLE PEPTIDE-HORMONES - GROWTH-HORMONE, PROLACTIN, AND HEMATOPOIETIC CYTOKINES [J].
HORSEMAN, ND ;
YULEE, LY .
ENDOCRINE REVIEWS, 1994, 15 (05) :627-649
[52]   The Stat family in cytokine signaling [J].
Ihle, JN .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (02) :211-217
[53]   Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain [J].
Iida, K ;
Takahashi, Y ;
Kaji, H ;
Nose, O ;
Okimura, Y ;
Abe, H ;
Chihara, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :531-537
[54]   Are SOCS suppressors, regulators, and degraders? [J].
Johnston, JA .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (05) :743-748
[55]   PHOSPHORYLATION AND ACTIVATION OF THE JAK-3 JANUS KINASE IN RESPONSE TO INTERLEUKIN-2 [J].
JOHNSTON, JA ;
KAWAMURA, M ;
KIRKEN, RA ;
CHEN, YQ ;
BLAKE, TB ;
SHIBUYA, K ;
ORTALDO, JR ;
MCVICAR, DW ;
O'SHEA, JJ .
NATURE, 1994, 370 (6485) :151-153
[56]   The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2 [J].
Kamizono, S ;
Hanada, T ;
Yasukawa, H ;
Minoguchi, S ;
Kato, R ;
Minoguchi, M ;
Hattori, K ;
Hatakeyama, S ;
Yada, M ;
Morita, S ;
Kitamura, T ;
Kato, H ;
Nakayama, K ;
Yoshimura, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12530-12538
[57]   The tertiary structure and backbone dynamics of human prolactin [J].
Keeler, C ;
Dannies, PS ;
Hodsdon, ME .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 328 (05) :1105-1121
[58]   Signaling through the JAK/STAT pathway, recent advances and future challenges [J].
Kisseleva, T ;
Bhattacharya, S ;
Braunstein, J ;
Schindler, CW .
GENE, 2002, 285 (1-2) :1-24
[59]  
Klug J, 2000, ANN NY ACAD SCI, V923, P348
[60]   Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor [J].
Kojima, M ;
Hosoda, H ;
Matsuo, H ;
Kangawa, K .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (03) :118-122